PFE is bouncing off support -- and, as a perennial powerhouse, we expect the stock to move back up toward its recent highs. More
- Poll of the Day
Pharmaceutical stocks have grown tremendously as medicine advances. With diseases like diabetes and even Ebola affecting more and more of the population, pharmaceutical companies are racing to find cures – further advancing medicine and driving their stock prices up. Corporations like Pfizer (NYSE:PFE) and Gilead Sciences (NASDAQ:GILD) are leading the charge against disease but smaller companies such as Myland (NASDAQ:MYL) are interesting investments as well.
Everything pharmaceutical companies thought they knew about Alzheimer's disease may (or may not) be wrong. More
Valeant Pharmaceuticals (VRX) swiped Salix Pharmaceuticals (SLXP) from Endo International (ENDP), but was it really worth it? More
The loss of exclusivity on blockbuster drugs continued to weigh in the top line at both Pfizer and Merck in the most recent quarter. More
Inovio Pharmaceuticals said that its shareholders had voted to approve a 1-for-4 reverse stock split. INO stock fell more than 5%. More